Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 9 Prostatic Neoplasms, Castration-Resistant 2 Urogenital Neoplasms 1 Rate of PSA Response in Oligometastatic,CRPC Undergoing SBRT in Combination With Abiraterone Acetate (AA), Compared to Patients Treated With AA Alone 1 Prostatic Diseases 1 Neoplasms by Site 1 Neoplasms 1 Metastatic Castration-resistent Prostate Cancer 1 Genital Neoplasms, Male 1 Genital Diseases, Male 1 Cushing Syndrome 1 Adrenocortical Carcinoma 1

Interventions

cabazitaxel 1 Sorafenib 1 Ritonavir 1 Radiotherapy 1 Paclitaxel 1 Nivolumab 1 Mitotane 1 Lymph Node Excision 1 Indinavir 1 IPI-549 1 Blood Specimen Collection 1 Adrenalectomy 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Adrenocortical Carcinoma × Abiraterone Acetate × Clear all

NCT03145285 2017-05-10

ABACUS

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 2 Unknown

Cushing Syndrome, Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡